These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37625022)

  • 1. Addressing the Evidence to Practice Gap: What to Expect From International Antipsychotic Dose Reduction Studies in the Tapering Anti-Psychotics and Evaluating Recovery Consortium.
    Koops S; Allott K; de Haan L; Chen E; Hui C; Killackey E; Long M; Moncrieff J; Sommer I; Stürup AE; Wunderink L; Begemann M;
    Schizophr Bull; 2024 Jan; 50(1):5-8. PubMed ID: 37625022
    [No Abstract]   [Full Text] [Related]  

  • 2. Correction to: Addressing the Evidence to Practice Gap: What to Expect From International Antipsychotic Dose Reduction Studies in the Tapering Anti-Psychotics and Evaluating Recovery Consortium.
    Schizophr Bull; 2024 Jan; 50(1):228-229. PubMed ID: 37713624
    [No Abstract]   [Full Text] [Related]  

  • 3. Brief report on Ziprasidone.
    Firoz AH; Rahman AH; Chowdhury WA; Mamun AA
    Mymensingh Med J; 2002 Jul; 11(2):129-32. PubMed ID: 12395687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-tapering trajectories in patients with remitted psychosis undergoing guided antipsychotic reduction to reach minimum effective dose.
    Liu CC; Hsieh MH; Chien YL; Liu CM; Lin YT; Hwang TJ; Hwu HG
    Eur Psychiatry; 2023 Aug; 66(1):e66. PubMed ID: 37578111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tapering Antipsychotic Treatment.
    Horowitz MA; Murray RM; Taylor D
    JAMA Psychiatry; 2021 Feb; 78(2):125-126. PubMed ID: 32777027
    [No Abstract]   [Full Text] [Related]  

  • 6. Gradually tapering off antipsychotics: lessons for practice from case studies and neurobiological principles.
    Horowitz MA; Moncrieff J
    Curr Opin Psychiatry; 2024 Jul; 37(4):320-330. PubMed ID: 38726815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experiences of guided tapering of antipsychotics for patients with schizophrenia- a case series.
    Mølgaard SN; Nielsen MØ; Roed K; Nielsen J
    BMC Psychiatry; 2024 Mar; 24(1):240. PubMed ID: 38553687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic drug treatment.
    Bennett J
    Nurs Stand; 1999 Mar 3-9; 13(24):49-53, 55-6. PubMed ID: 10335241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic drugs.
    Hudepohl NS; Nasrallah HA
    Handb Clin Neurol; 2012; 106():657-67. PubMed ID: 22608650
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-psychotic uses for anti-psychotics.
    Yang A; Koo JY
    J Drugs Dermatol; 2004; 3(2):162-8. PubMed ID: 15098971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic medications for children and adolescents.
    Gracious BL; Findling RL
    Pediatr Ann; 2001 Mar; 30(3):138-45. PubMed ID: 11257943
    [No Abstract]   [Full Text] [Related]  

  • 12. Chirality and drugs used to treat psychiatric disorders.
    Baker GB; Prior TI; Coutts RT
    J Psychiatry Neurosci; 2002 Nov; 27(6):401-3. PubMed ID: 12491572
    [No Abstract]   [Full Text] [Related]  

  • 13. The myth of the magic antipsychotic.
    Moncrieff J
    Ment Health Today; 2008 Jun; ():18-9, 22. PubMed ID: 18663800
    [No Abstract]   [Full Text] [Related]  

  • 14. Antipsychotic maintenance treatment versus dose reduction: how the story continues.
    Sommer IEC; Horowitz M; Allott K; Speyer H; Begemann MJH
    Lancet Psychiatry; 2022 Aug; 9(8):602-603. PubMed ID: 35753324
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clopixol: new possibilities in therapy of mental disorders (a review of clinical studies)].
    Litvintsev SV; Reznik AM; Arbuzov AL; Barkov DA
    Voen Med Zh; 2002 Mar; 323(3):42-7. PubMed ID: 11965908
    [No Abstract]   [Full Text] [Related]  

  • 16. [Neuroleptics: value and indications].
    Dupuy C
    Soins; 1994 Dec-1995 Jan; (591-592):49-50. PubMed ID: 7652607
    [No Abstract]   [Full Text] [Related]  

  • 17. The pharmacological management of behavioural disturbance in psychosis: a naturalistic study.
    Daniel J; Chamberlain J; Castle D
    Australas Psychiatry; 2007 Oct; 15(5):380-4. PubMed ID: 17828634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized drug therapy with pharmacogenetics--part 2: pharmacodynamics.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2006 Feb; 44(2):13-6. PubMed ID: 16526527
    [No Abstract]   [Full Text] [Related]  

  • 19. How do drugs for psychiatric disorders work?
    Harmer CJ; Cowen PJ
    Epidemiol Psychiatr Sci; 2018 Apr; 27(2):141-142. PubMed ID: 29117872
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials.
    Tani H; Takasu S; Uchida H; Suzuki T; Mimura M; Takeuchi H
    Neuropsychopharmacology; 2020 Apr; 45(5):887-901. PubMed ID: 31770770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.